...
Why us? Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

Author Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making.

MD MRCGP DFFP
Was this answer helpful?
Authored and medically reviewed by Dr Farzana Khan on 4 August 2026
Rate Dr Farzana's explanation
What is the risk of urethral erosion or migration when using periurethral b... | WHC Clinical FAQ

What is the risk of urethral erosion or migration when using periurethral b... | WHC Clinical FAQ

What is the risk of urethral erosion or migration when using periurethral b... | WHC Clinical FAQ

What is the risk of urethral erosion or migration when using periurethral b... | WHC Clinical FAQ

PRP and Incontinence

PRP and Incontinence

What are the clinical signs of synthetic mid-urethral sling mesh erosion into the vagina or urethra?

What are the clinical signs of synthetic mid-urethral sling mesh erosion into the vagina or urethra?




Scar tissue


Lesion review


May defer

Women’s Health Clinic FAQ

How does the presence of an active urethral caruncle alter needle trajectory during periurethral PRP infiltration?

Previous surgery, scarring or active urethral lesions can change whether O-Shot treatment should proceed at all.

Direct answer

An active urethral caruncle should shift the discussion from needle trajectory to assessment, deferral or referral. The key point is to explain why visible urethral lesions and urinary symptoms need diagnosis before periurethral PRP is considered.

The useful answer separates patient education from clinician-only technique, so the reader understands what to ask without being given procedural instructions.


Educational only. Use this as general education before discussing your own symptoms with a clinician. Results vary. Not a cure.

Women's Health Clinic consultation for How does the presence of an active urethral caruncle alter needle trajectory during periurethral PRP infiltration?

O-Shot safety review

At a glance

These points keep the technical question useful without turning it into a procedure guide.

At a glance

Clinical summary

Different tissue

Anterior colporrhaphy, episiotomy scarring and active lesions can alter tissue planes and tenderness.

No trajectory advice

Needle trajectory or adapted technique should not be described as public guidance.

May need referral

Urethral caruncles, bleeding, pain or urinary symptoms may need assessment before PRP.

Consent changes

Scarring can affect comfort, diffusion assumptions, risk discussion and follow-up.

Important safety note

Seek medical advice promptly for heavy or persistent bleeding, fever, offensive discharge, ulcers, severe pelvic or vulval pain, urinary retention, worsening swelling, suspected infection, active urethral lesions or symptoms that feel unusual after treatment.

Scarring
Lesion
Assessment
Deferral
Referral




Detailed answer

Detailed answer

Scar tissue and previous surgery can change tissue mobility, sensitivity and anatomical planes.

Clinical context

An active urethral caruncle or unexplained lesion should shift attention from technique to diagnosis, deferral or referral.

Mechanism
Anatomy
Safety
Evidence

What matters first

Scar tissue and previous surgery can change tissue mobility, sensitivity and anatomical planes.

Why it is clinician-led

An active urethral caruncle or unexplained lesion should shift attention from technique to diagnosis, deferral or referral.

Evidence boundary

A public answer should explain why assessment matters without teaching adapted injection paths or lesion workarounds.

Safety boundary

The aim is to protect comfort, avoid traumatising fragile tissue and make sure symptoms are not being misattributed.

What this means in practice

A useful answer explains the safety logic without publishing anaesthetic, injection, device or aftercare techniques.

Exact procedural decisions should be confirmed by the treating clinician after examination, consent and review of symptoms.





Patient safety

Why this matters

Technical O-Shot questions matter because genital tissue is sensitive, vascular and affected by anatomy, pain, hormones, scarring and urinary symptoms.

It avoids false precision

A ratio, angle or technique can sound precise while being unsafe outside clinical context.

It protects sensitive tissue

Vulval, vaginal, clitoral and periurethral tissue may be fragile, painful, scarred or inflamed.

It supports consent

Patients should understand why some details are withheld and what questions to ask before treatment.

It keeps evidence honest

Intimate PRP studies use variable protocols, so outcomes should not be promised from anatomy or device language.

A careful treatment conversation

The right question is not only how a procedure is performed, but whether the symptom, tissue and medical history make it appropriate.

That is why assessment, consent and follow-up are central to responsible intimate PRP care.





Considerations

What to consider

Consider the symptom target, tissue health, pain, urinary symptoms, scarring, menopause status, medicines, infection symptoms, bleeding history and treatment goals.

Consultation priorities

The consultation reviews surgical history, childbirth tears, episiotomy scars, prolapse repair, urinary symptoms, bleeding and pain.

Symptoms
Tissue
Safety
Follow-up

Assessment

The consultation reviews surgical history, childbirth tears, episiotomy scars, prolapse repair, urinary symptoms, bleeding and pain.

Safety review

The clinician examines tissue and considers whether a lesion, infection, GSM, pelvic-floor pain or scarring needs separate management.

Treatment fit

If PRP is still considered, consent should explain why technique, comfort and expectations may differ.

Review

Review is important for pain, bleeding, urinary symptoms, swelling or concern that a lesion has changed.

Practical expectations

Response can be partial, delayed or absent, and published intimate PRP protocols are not uniform.

Prices, exact procedural details, treatment timing and aftercare should be confirmed with the clinic before booking.





Common concerns and myths

Common misconceptions

These myths can make technical O-Shot questions sound more controllable than they really are.

Myth: previous surgery makes no difference

Reality: scar tissue can change tenderness, tissue planes and suitability.

Myth: scar tissue simply needs more PRP

Reality: pain and scarring need diagnosis, not volume assumptions.

Myth: a urethral lesion can be worked around

Reality: active lesions should be assessed before periurethral injection.

Evidence and context

Mechanism helps explain why PRP is considered, but it does not replace diagnosis, clinical evidence or suitability checks.

Different outcomes

Comfort, arousal, lubrication, orgasm, urinary symptoms and pain are different outcomes and should not be blurred together.





Safety checklist

Safety checklist

Use these checks before assuming intimate PRP is suitable.

Is the symptom clear?

Clarify whether the concern is orgasm, arousal, lubrication, pain, sensitivity, urinary leakage or tissue comfort.

Has tissue context been reviewed?

Scarring, menopause-related change, infection symptoms, urinary issues and active lesions can affect suitability.

Are red flags absent?

Pause and seek clinical review for new bleeding, fever, offensive discharge, ulcers, severe pain, urinary retention, spreading swelling, active urethral lesions or any concern about infection.

Is uncertainty documented?

Consent should explain limited evidence, variable response and possible discomfort, bruising or bleeding.

Reassuring signs

Proceeding is more reasonable when symptoms are clearly assessed, red flags are absent and expectations are realistic.

Clear goal
No red flags
Review plan

Reasons to pause

Pause for new bleeding, infection symptoms, ulcers, severe pain, urinary retention, spreading swelling, active urethral lesions or uncertainty about medicine safety.

Bleeding
Infection
Severe pain




When to escalate

When to seek medical help

Some symptoms around intimate PRP treatment need prompt assessment.

Use NHS 111 online

Bleeding

Heavy bleeding, persistent bleeding or bleeding after sex should be assessed by a clinician.

Infection symptoms

Fever, offensive discharge, worsening burning, ulcers or pelvic pain may need swabs, urine testing or review.

Unexpected reaction

Worsening swelling, severe soreness, prolonged numbness or tissue colour change should be reviewed.

Emergency symptoms

Call 999 in a life-threatening emergency, including collapse, chest pain, breathing difficulty or sudden neurological symptoms.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

More clinical detail

Why scarring changes the conversation

Scar tissue may be less mobile, more tender or anatomically different. That can affect comfort, consent and whether treatment is suitable.

Why lesions need assessment

A urethral caruncle or unexplained vulval finding should be diagnosed before elective periurethral PRP is considered.

Next step

Book an intimate health consultation

A consultation can clarify whether symptoms fit GSM, sexual-function concerns, pelvic-floor pain, urinary symptoms or another cause, and whether PRP is suitable.

View Research Sources (12 Sources)
• O-Shot official questions
• O Shot and G Shot London competitor page
• PRP injections for female sexual dysfunction and SUI systematic review
• NHS pain during or after sex
• NHS vaginal dryness
• PRP in vulvovaginal disorders systematic review
• Role of PRP in pelvic floor disorders systematic review
• Skin Excellence O-Shot competitor page
• NHS local anaesthesia
• NHS urinary tract infections
• NICE HTG582 energy-based therapies for GSM
• CQC infection prevention and control

These 12 source names are selected from 97 curated sources. Additional reviewed material included peer-reviewed clinical papers, evidence reviews, clinical trial records; duplicate and low-relevance records were removed before display.

Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.

  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.